November 18th, 2026Eczema linked to higher odds of sleep disturbance in childrenEczema was linked to 28% higher odds of sleep disturbance in a 26,395-patient pediatric primary care cohort presented at ACAAI 2026.Read more
November 16th, 2026Roflumilast cream 0.05% eases itch, improves QOL in infants with ADCaregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.Read more
November 12th, 2026Risankizumab shows 52-week efficacy in pediatric psoriasis trialFull OptIMMize-1 results show high skin clearance rates with risankizumab in children and teens with psoriasis, sustained through 52 weeks.Read more
November 10th, 2026Exploring AhR agonists in pediatric atopic dermatitisEmily Becker, MD, discusses the role of AhR agonists, skin barrier function, and steroid-free treatment options for pediatric atopic dermatitis.Read more
November 9th, 2026Air pollution tied to higher pediatric atopic dermatitis burdenA meta-analysis of 52 studies links NO2, SO2, and particulate matter to more pediatric atopic dermatitis visits and higher prevalence.Read more
October 20th, 2026Recognizing skin conditions in children with darker skin tonesChristina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment gaps.Read more
November 20th, 2026Contemporary Pediatrics week in review: November 16-20, 2026Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.Read more
November 20th, 2026FDA approves once-weekly somapacitan for children with Turner syndromeThe FDA approved once-weekly somapacitan-beco for growth failure in Turner syndrome in children aged 2.5+ years, based on phase 3 REAL8 data.Read more